Cello Group

Cello is an insight and strategic marketing group, listed on London’s AIM (ticker: CLL).
Cello is comprised of two distinct businesses: Cello Health and Cello Signal. Cello Health delivers cutting-edge professional marketing services to the global pharmaceutical and health sectors. Cello Signal delivers technically-led insight and marketing support services to global consumer and business-to-business clients.
Cello’s overall mission is to cut through the increasing clutter of market data and discover the real value of market information, allowing our clients across both of our businesses to make faster and better market decisions.
Cello delivers its services from office networks in the UK, USA, Singapore and Hong Kong, through a group of over 800 professionals.”

Company growth
Type
Public
HQ
London, GB
Founded
2004
Size (employees)
38 (est)
Cello Group was founded in 2004 and is headquartered in London, GB

Key People at Cello Group

Mark Scott

Mark Scott

CEO
Jacqueline Briggs

Jacqueline Briggs

Vice President, Human Resources
Stephen Highley

Stephen Highley

Group Chief Operating Officer
Mark Bentley

Mark Bentley

Group Finance Director

Cello Group Office Locations

Cello Group has office in London
London, GB

Cello Group Metrics

Cello Group Summary

Market capitalization

£101 M

Closing share price

£1.17
Cello Group's current market capitalization is £101 M.

Cello Group Financials

Cello Group's revenue is £157 M in FY, 2015 which is 7.39% decrease from the previous period.
FY, 2015FY, 2014FY, 2013

Revenue

£157 M£170 M£160 M

Revenue growth, %

-7.4%6.4%

Cost of sales

£70.6 M£88.9 M£85 M

Gross profit

£86.7 M£81 M£74.7 M

Gross profit Margin, %

55.1%47.7%46.8%

Operating expense total

£81.5 M£76.8 M£68.7 M

Cello Group Market Value History

We estimate that Cello Group's current employees are approximately 21% female and 79% male.

Cello Group Online Presence

Cello Group Company Life

You may also be interested in